These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33574121)

  • 21. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus.
    Kawashima K; Meyerholz DK; Gallup JM; Grubor B; Lazic T; Lehmkuhl HD; Ackermann MR
    Viral Immunol; 2006; 19(2):316-23. PubMed ID: 16817774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
    Jalink MB; Langley JM; Dodds L; Andreou P
    Pediatr Infect Dis J; 2019 Nov; 38(11):1121-1125. PubMed ID: 31425330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    Chirikov VV; Simões EAF; Kuznik A; Kwon Y; Botteman M
    J Infect Dis; 2020 Mar; 221(8):1244-1255. PubMed ID: 30982895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
    Welliver TP; Reed JL; Welliver RC
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.
    Mochizuki H; Kusuda S; Okada K; Yoshihara S; Furuya H; Simões EAF;
    Am J Respir Crit Care Med; 2017 Jul; 196(1):29-38. PubMed ID: 28152315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of early life immune responses to RSV infection.
    Ruckwardt TJ; Morabito KM; Graham BS
    Curr Opin Virol; 2016 Feb; 16():151-157. PubMed ID: 26986236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine responses in cord blood predict the severity of later respiratory syncytial virus infection.
    Juntti H; Osterlund P; Kokkonen J; Dunder T; Renko M; Pokka T; Julkunen I; Uhari M
    J Allergy Clin Immunol; 2009 Jul; 124(1):52-58.e1-2. PubMed ID: 19482350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
    Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
    J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus: the virus, the disease and the immune response.
    Ogra PL
    Paediatr Respir Rev; 2004; 5 Suppl A():S119-26. PubMed ID: 14980256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation.
    Simões EA; Anderson EJ; Wu X; Ambrose CS
    PLoS One; 2016; 11(11):e0166226. PubMed ID: 27898687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.
    Bont L; Kimpen JL
    Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis.
    Cetinkaya M; Oral TK; Karatekin S; Cebeci B; Babayigit A; Yesil Y
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1629-1634. PubMed ID: 28391538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RSV hospitalization in infancy increases the risk of current wheeze at age 6 in late preterm born children without atopic predisposition.
    Korsten K; Blanken MO; Buiteman BJM; Nibbelke EE; Naaktgeboren CA; Bont LJ; Wildenbeest JG
    Eur J Pediatr; 2019 Apr; 178(4):455-462. PubMed ID: 30637465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.
    Le Nouën C; Hillyer P; Levenson E; Martens C; Rabin RL; Collins PL; Buchholz UJ
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: A cohort study.
    Benítez-Guerra D; Piña-Flores C; Zamora-López M; Escalante-Padrón F; Lima-Rogel V; González-Ortiz AM; Guevara-Tovar M; Bernal-Silva S; Benito-Cruz B; Castillo-Martínez F; Martínez-Rodríguez LE; Ramírez-Ojeda V; Tello-Martínez N; Lomelí-Valdez R; Salto-Quintana J; Cadena-Mota S; Noyola DE
    Influenza Other Respir Viruses; 2020 Mar; 14(2):182-188. PubMed ID: 31917902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response.
    Hoffman SJ; Laham FR; Polack FP
    Microbes Infect; 2004 Jul; 6(8):767-72. PubMed ID: 15207824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthy Late-preterm infants born 33-36+6 weeks gestational age have higher risk for respiratory syncytial virus hospitalization.
    Helfrich AM; Nylund CM; Eberly MD; Eide MB; Stagliano DR
    Early Hum Dev; 2015 Sep; 91(9):541-6. PubMed ID: 26186560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.
    Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA
    J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.
    Welliver TP; Garofalo RP; Hosakote Y; Hintz KH; Avendano L; Sanchez K; Velozo L; Jafri H; Chavez-Bueno S; Ogra PL; McKinney L; Reed JL; Welliver RC
    J Infect Dis; 2007 Apr; 195(8):1126-36. PubMed ID: 17357048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.